Skip to content

Study of Information Received About Fertility and Infertility in Patients Who Have Finished Treatment for Cancer

Descriptive Study to Evaluate the Information and Psychosocial Issues on the Risk on Infertility in Cancer Patients After Receiving Treatment in a Comprehensive Cancer Center

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01295463
Enrollment
96
Registered
2011-02-14
Start date
2010-12-31
Completion date
Unknown
Last updated
2013-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

sexual dysfunction, psychosocial effects of cancer and its treatment, infertility, colon cancer, male breast cancer, breast cancer, germ cell tumor, ovarian sarcoma, uterine sarcoma, chronic lymphocytic leukemia, osteosarcoma, chronic myelogenous leukemia, non-Hodgkin lymphoma, adult acute myeloid leukemia with 11q23 (MLL) abnormalities, adult acute myeloid leukemia with inv(16)(p13;q22), adult acute myeloid leukemia with t(15;17)(q22;q12), adult acute myeloid leukemia with t(16;16)(p13;q22), adult acute myeloid leukemia with t(8;21)(q22;q22), mast cell leukemia, hairy cell leukemia, prolymphocytic leukemia, adult acute lymphoblastic leukemia, adult acute myeloid leukemia, adult Hodgkin lymphoma, adult T-cell leukemia/lymphoma, small intestine lymphoma, anaplastic large cell lymphoma, angioimmunoblastic T-cell lymphoma, mycosis fungoides/Sezary syndrome, intraocular lymphoma, primary central nervous system non-Hodgkin lymphoma, primary central nervous system Hodgkin lymphoma, noncutaneous extranodal lymphoma, secondary acute myeloid leukemia, acute undifferentiated leukemia, central nervous system leukemia, T-cell large granular lymphocyte leukemia, atypical chronic myeloid leukemia, BCR-ABL1 negative, clear cell sarcoma of the kidney, Kaposi sarcoma, adult soft tissue sarcoma, chronic myelomonocytic leukemia, secondary central nervous system Hodgkin lymphoma, cutaneous lymphoma, adult non-Hodgkin lymphoma

Brief summary

RATIONALE: Learning about the amount of information on fertility and infertility by patients before they received treatment for cancer in a comprehensive cancer center may help doctors plan the best treatment. PURPOSE: This clinical trial is studying the amount of information on fertility and infertility received by patients before treatment of cancer in patients who have finished treatment.

Detailed description

OBJECTIVES: Primary * To determine the amount of information received on aspects of fertility and infertility in patients with cancer prior to receiving treatment in a comprehensive cancer center. Secondary * To analyze whether the information received by patients is related to the desire to be parents. * To analyze whether the information received by patients is related to the desire to be informed. * To determine whether there is a relationship between demographic data, diagnosis, quality of life, and associated psychosocial information received by patients. OUTLINE: Patients complete questionnaires (Lickert and QLQ-C30) on the amount of information received prior to therapy and psychosocial issues on aspects of fertility and infertility once within 1-2 years after receiving treatment.

Interventions

OTHERquestionnaire administration
OTHERstudy of socioeconomic and demographic variables
PROCEDUREassessment of therapy complications
PROCEDUREpsychosocial assessment and care
PROCEDUREquality-of-life assessment

Sponsors

Institut Català d'Oncologia
Lead SponsorOTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

DISEASE CHARACTERISTICS: * Diagnosis of breast cancer, germ cell tumor, colon cancer, leukemia, lymphoma, or sarcoma * Free of disease * Completed treatment within the past 1-2 years PATIENT CHARACTERISTICS: * ECOG performance status 0-1 * Must be able to read and self-complete study questionnaires * No psychological conditions that may prevent participation in the study PRIOR CONCURRENT THERAPY: * See Disease Characteristics * No concurrent treatment (hormonal treatment for breast cancer is allowed)

Design outcomes

Primary

MeasureTime frame
Amount of information received on aspects of fertility and infertility
Relationship between demographic data, diagnosis, quality of life, and associated psychosocial information received

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026